$OCUP

Ocuphire Pharma Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$1.89 ▼-1.563%

Last Close

VOLUME

124,854

DAY RANGE

1.85 - 1.92

52 WEEK

1.78 - 5.5

Join Discuss about OCUP with like-minded investors

profile
@TraderXx #StockTraders.NET
recently

$OCUP with a twist

41 Replies 9 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

watchlist for monday: $GOVX, $APT, $PTN, $NRXP, $BFRI, $OCUP, $AHPI

74 Replies 6 👍 11 🔥

SO
@soheil.n #StockTraders.NET
recently

yep..i even spelled it out 4.5-4.7 but didn't take it 🤦‍♂️ > @maletone said: damn, $OCUP

131 Replies 15 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

damn, $OCUP

65 Replies 9 👍 11 🔥

SO
@soheil.n #StockTraders.NET
recently

$Ocup moving

49 Replies 12 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

$GOVX, $APT, $BIMI, $OCUP $TOMZ watching for short enries

57 Replies 15 👍 15 🔥

SO
@soheil.n #StockTraders.NET
recently

IU Watchlist: Main Watches: $BFRI I think unwinds tomorrow - hopefully has a gap up but we'll see. Relatively thin float but feels very long crowded. Kept shorts in all day forced them out at close but not so much a squeeze more so just a big share scalp I think for the float soak team. $F been an okay trader but -- focusing for the next move. I still think we could have a dunk but I am not aggressively biased but what I do think is we have a $2 move close. If that's $18 or $22 we'll see - but I am VERY focused here w/ a plan to be patient w/ whatever move it decides. Failed Follow Through: $OCUP higher better and back side - killer fade on Wednesday probably traded it TOO safe but solid opportunity. Would love another opp for morning shove to fade it off again. If trend firms up over VWAP cautious fighting. $LGVN I think everyone that had size got blown out clean unwind AHs - to me it just seems like someone soaked the float twice and did a big share scalp - if you noticed twice now it peaked at the same $45 range level - always look left. Not an easy trade with all the circuits but should be a clean move if shoves up in the AM likely just fades off through the day. $APVO higher better and failed follow through set ups. $BBY good plan on last scan - worked well. Looking for same - higher better in AM and looking to unwind. Continuation: $AVRO watch if firms up over $5 - had an orphan designation on Wednesday with no PR yet. Moved up some AHs - still long from that dip buy. $TRT nice break out Wednesday - still long here and been adding. Like all of them if it fails to continue I'll size back out ie: PPSI etc. Not everything will work this well but once they stop going up or shoulda gone up or break key support either bail or size out before it becomes an issue. $HCDI so far so good from last Sunday scan. $IMCC nice trend join so far $PME possible trend join - no position yet.

55 Replies 9 👍 14 🔥

SO
@soheil.n #StockTraders.NET
recently

well that didn't go the way i envisioned it 🤷‍♂️ > @soheil.n said: have a feeling $OCUp might rip in the afternoon...been holding up the 4.6s all day

44 Replies 14 👍 13 🔥

SO
@soheil.n #StockTraders.NET
recently

have a feeling $OCUp might rip in the afternoon...been holding up the 4.6s all day

51 Replies 6 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$OCUP close again

60 Replies 12 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

$OCUP feels finished

53 Replies 7 👍 10 🔥

SO
@soheil.n #StockTraders.NET
recently

$OCUP - too choppy right now 4.6-5 channel

53 Replies 15 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

covered a ton in that wash on $OCUP

120 Replies 13 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

watching $OCUP again

42 Replies 6 👍 9 🔥

profile
@TraderXx #StockTraders.NET
recently

$APVo fueling $OCUP

99 Replies 6 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

all out $OCUP for now

119 Replies 9 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

not to say $OCUp hasn't been a winner

117 Replies 7 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

coverd some more $OCUP

119 Replies 10 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

$OCUP crack 480's 4.70's

135 Replies 6 👍 14 🔥

ST
@stevengo #StockTraders.NET
recently

Liking $13 > @Math said: $OCUP trades real heavy

97 Replies 8 👍 6 🔥

profile
@Math #StockTraders.NET
recently

$OCUP trades real heavy

110 Replies 14 👍 11 🔥

profile
@dros #droscrew
recently

1000 $OCUP DEC2021 $7.5 Cs trade 0.3

100 Replies 14 👍 15 🔥

profile
@dros #droscrew
recently

1000 $OCUP DEC2021 $7.5 Cs trade 0.3

98 Replies 7 👍 10 🔥

profile
@CarlosH-carvan #ivtrades
recently

$OCUP sweep 7.5tC Dec17

135 Replies 9 👍 8 🔥

profile
@TraderXx #StockTraders.NET
recently

Patience with $OCUP my friends!

52 Replies 12 👍 14 🔥

profile
@dros #droscrew
recently

$OCUP new atlas play

123 Replies 7 👍 11 🔥

profile
@thegiz18 #ivtrades
recently

Back in $OCUP for another sip

117 Replies 15 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

yes!!! $OCUP

138 Replies 13 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

decent pop on $OCUP

147 Replies 13 👍 11 🔥

profile
@dros #droscrew
recently

Upgrades 11/24: $AEG $CVX $DEO $DLTR $FMX $GRUB $SYBX $YSG .. Downgrades 11/24: $BABA $BBY $GPS $HTA $JACK $JWN $NOAH $PLAN $RPM $TITN +Initiations 11/24: $AURA $AVY $BFRI $BTTX $CFG $DSEY $GPK $LIAN $MYNA $OCUP $PLRX $SLGN $SPAQ $SPOT $TRDA .. -Initiations 11/24:

63 Replies 15 👍 12 🔥

SO
@soheil.n #StockTraders.NET
recently

$OCUP i had the levels drawn to hold to...but didn't make it far

40 Replies 10 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

will cover some $OCUP soion

89 Replies 11 👍 12 🔥

profile
@TraderXx #StockTraders.NET
recently

$OCUP $6.50's - 7's target ss area for me

119 Replies 15 👍 13 🔥

profile
@TraderXx #StockTraders.NET
recently

$OCUP will be a good ss today, I can feel it

83 Replies 8 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

added back to $OCUP

147 Replies 7 👍 9 🔥

SO
@soheil.n #StockTraders.NET
recently

$OCUP will most likely surpass the june 30th vol.

103 Replies 6 👍 11 🔥

SO
@soheil.n #StockTraders.NET
recently

all out $OCUP

96 Replies 14 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

downsized a little into that move on $OCUP

129 Replies 14 👍 12 🔥

SO
@soheil.n #StockTraders.NET
recently

$OCUP - vwapblvd at 6.08 from June 30th

81 Replies 10 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

nic fail on $OCUP

63 Replies 9 👍 15 🔥

profile
@thegiz18 #ivtrades
recently

In and out of $OCUP, $600 plus but exited too early

47 Replies 12 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

$OCUP needs to stay under 5.80 -5'60

113 Replies 11 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

added some more $OCUP\

107 Replies 13 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

nice volume bar on $OCUP

78 Replies 9 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

will cover some $OCUP under 5.40's

147 Replies 9 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

would have been easier to let $OCUP just hit the hod

96 Replies 13 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

nice $OCUP avg is 5.84

112 Replies 14 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

added more to my $ocup but may wait for open to really add

75 Replies 7 👍 14 🔥

profile
@thegiz18 #ivtrades
recently

$OCUP on the move, signing up for phase 3 trial and upgrade by Wainwright to $26

132 Replies 7 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

shorting some $ocup here but could go much higher

83 Replies 12 👍 8 🔥

Key Metrics

Market Cap

36.60 M

Beta

0.89

Avg. Volume

114.39 K

Shares Outstanding

19.36 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

Ocuphire is a publicly traded, clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline currently includes two small- molecule product candidates targeting front and back of the eye indications. The company's lead product candidate, Nyxol® Eye Drops, is a once-dailypreservative-free eye drop formulation of phentolamine mesylate, a non-selectivealpha-1 and alpha-2 adrenergic antagonist designed to reduce pupil size, and is being developed for several indications, including dim light or night vision disturbances (NVD), reversal pharmacologically-induced mydriasis (RM), and presbyopia. Ocuphire's second product candidate, APX3330, is a twice- a-day oral tablet, designed to inhibit angiogenesis and inflammation pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy (DR) and diabetic macular edema (DME). Nyxol is entering Phase 3 clinical development for NVD and RM, and Phase 2 for presbyopia. APX3330 is entering Phase 2 clinical development for DR/DME. As part of its strategy, Ocuphire will continue to explore opportunities to acquire additional ophthalmic assets and to seek strategic partners for late stage development, regulatory preparation and commercialization of drugs in key global markets.

CEO: Douglas Swirsky

Website:

HQ: 15245 Shady Grove Rd Ste 455 Rockville, 20850-7203 Maryland

Related News